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Abstract Imaging of cardiac function and anatomy has
advanced at an exponential rate over the past two decades.
Our ability to quantitatively assess the degree of myocardial
ischemia and accurately define the vascular anatomy using
noninvasive techniques is greater than ever before. Current
advances is cardiac imaging are allowing us to more safely
assess patients for myocardial ischemia and better understand
the prognostic implications of our findings. This review
summarizes the current state of knowledge in cardiac imaging
for the assessment of cardiac ischemia with a focus on the use
of cardiac MRI.
Keywords Cardiac imaging.Cardiovascular magnetic
resonance imaging.Cardiac computed tomography.
Ischemia.Vascular imaging.Perfusion.SPECT.Stress
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Introduction
The last decade has seen exponential growth in the
diagnostic modalities available to the clinician for the
assessment of coronary artery disease (CAD). While this
growth in technology has been accompanied by important
advancements in the management of acute coronary
syndromes, less progress has been observed in the
treatment of chronic stable CAD. This lack of therapeutic
progress in the management of chronic forms of coronary
disease is disappointing in some respects; however, there is
no question that substantial advances have occurred in both
our ability to image the disease and our understanding of
the significance of the findings that are made. These
advances have improved not only our understanding of
the prognostic features that are vital in the treatment of
CAD, but they also are likely to ultimately result in
improved outcomes. This review will attempt to illuminate
how recent advances in cardiac imaging, with a focus on
cardiac MRI, are likely to translate into improved cardiac
care in the future. Fig. 1.
Diagnosis and Prognosis: Two Sides of the Same Coin
The imaging modalities available for the assessment of CAD
canbebroadlydividedintotwogroups:thosethatcharacterize
theluminalanatomyofCAD(i.e.,CTangiography),andthose
that characterize the functional consequences of CAD (i.e.,
stress echocardiography). Imaging modalities that detect
anatomical CAD are generally more sensitive to detect
coronary artery stenosis; however, imaging modalities that
detect functional ischemia may provide more information on
the relevance of a stenosis and its impact on prognosis.
Cardiac MRI (CMR) is somewhat uniquely placed in that it
bridges both the anatomic and functional domains of cardiac
imaging (Table 1).
There is an important distinction to be made in the nature
of the information obtained from anatomic and functional
noninvasive imaging techniques. While anatomic charac-
terization of coronary disease is of great utility in both
initial diagnosis of CAD and subsequent planning for
revascularization, functional testing represents the more
powerful determinant for selecting the appropriate therapy
and estimate prognosis. Baseline left ventricular function
A. G. Howarth: M. G. Friedrich (*)
University of Calgary,
Suite 700, SSB, 1403 29th Street NW,
Calgary, AB, Canada, Canada
e-mail: matthias.friedrich@ucalgary.ca
Curr Cardiovasc Imaging Rep (2011) 4:90–97
DOI 10.1007/s12410-011-9068-6and objective demonstration of ischemia are strongly
associated with outcomes. Mistakenly, noninvasive imaging
is often carried out solely to make a determination as to the
likelihood of the presence of CAD. If the likelihood is
deemed high, the patient is referred for coronary angiogra-
phy, which then dictates future management based only on
the anatomic appearance of the coronary vessel lumen.
Except in the most severe forms of CAD [1], evidence
advising against revascularization without objective data
demonstrating evidence of myocardial ischemia has been
available for many years [2]. It is thus necessary to obtain
both functional and anatomic information regarding CAD
in order to design an appropriate and rational treatment
strategy in any given patient.
The rationale against revascularization on the basis of
anatomy alone was recently underscored with the publica-
tion of the COURAGE trial [3]. This study threw into
question the wisdom of basing percutaneous coronary
intervention decisions solely on the angiographic appear-
ance ofcoronary disease. In this large multicenter randomized
controlled trial, percutaneous coronary intervention did not
reduce the risk of death or myocardial infarction when
compared to medical therapy alone. However, a substudy
population of this trial, which was further stratified for
ischemic burden, did show a trend towards benefit of
revascularization when the ischemic burden was high [4].
More recently, evidence has accumulated that demonstrates
the value of demonstrating a functional ischemic burden
when making revascularization decisions for CAD [5, 6￿].
The need for both anatomic and functional imaging
modalities in the assessment of cardiac ischemia remains
clear.
Ideally, we will reach the point where only patients who
are very likely to benefit from invasive revascularization
procedures will be exposed to the risks inherent in these
techniques. All others will be excluded through the
appropriate application of sensitive and specific diagnostic
imaging. Clinical research should give guidance for these
important questions.
Imaging as an End Point
A functional approach to the diagnosis of CAD relies on
imaging modalities that demonstrate myocardial ischemia.
These techniques include nuclear imaging, stress echocar-
diography, PET, and CMR perfusion protocols. The
evidence that supports the use of these techniques usually
considers the identification of significant CAD (>50%
narrowing of a coronary artery) at coronary angiography
as the gold standard against which the technique is
assessed. Table 2 outlines the sensitivity and specificity of
the various imaging modalities. Generally, the performance
of these tests can be considered very good, but not
diagnostic by itself. Thus, clinical judgment still plays an
important role in patient management.
More recently, the use of CT has become prevalent in the
diagnosis of CAD. Techniques range from coronary
calcium scoring to the multislice CT determination of
coronary anatomy. These techniques do not depend on the
presence of myocardial ischemia for the identification of
CAD, and therefore are likely to detect the presence of
Fig. 1 Venn diagram showing the relationship between ischemic
burden in the myocardium and the various imaging modalities. LV
wall motion abnormalities detect higher burdens of myocardial
ischemia, while angiography detects coronary artery disease across a
wide range of ischemic burdens
Table 1 Relative strengths of imaging modalities
Anatomy Stress-function Stress-perfusion Oxygenation Prognosis
SPECT − ++ + − +++
PET −− +++ + ++
CMR ++ +++ ++ ++ +
Echocardiography ++ +++ +/−− +++
CT angiography +++ − +/−− +
Relative performance of the available cardiac imaging modalities stratified into domains. Modalities that provide strong anatomic information on
the coronary vasculature tend to perform less well in the functional domains, while modalities providing functional information tend to be limited
in anatomic data. Cardiac MR is unique in its relative balance of information across domains. Prognostic information is most closely related to the
age of the modality, reflecting the time required for this evidence to accumulate
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widespread use of CT is likely to remain constrained by the
radiation dose, this modality currently offers a diagnostic test
of high accuracy.
When considering the value of any imaging technique, it
is important to keep in mind the expected outcomes from
any given result. The identification of minor vessel
irregularities on a multislice CT does not likely carry the
same prognostic significance as would the presence of
severe inducible wall motion abnormalities identified
during stress echocardiography. Indeed, the evidence on
clinical outcomes, which support the established methods
of ischemia imaging, are a substantial advantage of the
older techniques. Newer modalities have not yet sufficiently
well demonstrated their prognostic significance, although
such studies are underway. More importantly, though, even
standard techniques are not backed up by data showing that
therapeutic decision-making based on such findings actually
improves outcome, regardless of mere diagnostic accuracy
and predictive value.
Relevant outcomes in ischemia trials include not only
death, but also markers such as resolution of ST elevation,
symptoms, arrhythmia, heart failure, hospitalizations, and
quality of life. When assessing the utility of an imaging end
point, it is important to consider the relationship that the
imaging result has with these factors.
Perfusion Imaging
Scintigraphy
There is a substantial body of evidence that supports the use
of ischemia imaging as a clinically relevant end point. This
is particularly true of the nuclear medicine literature. A
meta analysis of single-photon emission CT (SPECT)
imaging, which included 69,655 patients referred for risk
stratification, concluded that the presence of a moderate or
severe perfusion defect was associated with an annual hard
event rate of 5.9%, while a normal SPECT scan was
associated with an annual risk of death or myocardial
infarction (MI) of only 0.85%, a rate which is comparable to
that of the general population [7]. Similarly, an abnormal
perfusion scan using rubidium positron emission tomography
in patients with known or suspected CAD is associated with
an annual risk of death of 4.3%, while a normal study is
associated with an annual mortality rate of 0.9% [8].
A general limitation of all perfusion techniques may
arise from the presence of microvascular disease in
diabetes, hypertension, and hypercholesterolemia. Micro-
vascular disease is hypothesized to result in impaired
perfusion in the absence of significant epicardial stenosis.
This is thought to partially explain (the other reason being
the low incidence of disease in the study population) why
SPECT’s specificity is never found to be much higher than
75% to 80%. It is of interest that this lower specificity is not
reflected in worsened prognostic power, suggesting that
microvascular disease remains an important prognostic
determinant.
Cardiac MRI
While nuclear perfusion imaging techniques are well
established, they are increasingly compromised by con-
cerns about radioactivity as well as more recent concerns
surrounding isotope supply problems. Fortunately, the
utility of stress perfusion CMR as an evidence-based
diagnostic technique is also improving. MR-IMPACT
was a multicenter head-to-head comparison of stress
perfusion CMR and nuclear perfusion imaging that found
the two techniques approximately equivalent in CAD
detection [9￿]. This study was an important contribution to
the field, as it provided strong evidence in support of
CMR-based perfusion imaging. A recent meta analysis of
the diagnostic performance of stress perfusion CMR which
included 2,125 patients enrolled in 26 studies, reported an
overall sensitivity of 89% and a specificity of 80% [10￿￿]
of CMR stress perfusion when compared to the gold
standard of coronary angiography. As discussed above, the
relatively low specificity of CMR perfusion protocols is
argued to be in part due to its sensitivity in identifying
microvascular coronary disease which is not associated
with epicardial stenosis [11].
The prognostic evidence supporting stress perfusion CMR
ismorelimitedthanthe diagnosticcharacterizationofthe test,
butisincreasing.Jahnkeetal.[12] performed stress perfusion
CMR studies on 513 patients with known or suspected
CAD. During a median follow-up of 2.3 years, a positive
scan was associated with a hazard ratio of 12.5 (CI=3.6–43)
for cardiac events [12]. A recent study of 103 patients
presenting to the emergency department with low-risk chest
Table 2 Pooled sensitivity and specificity data for imaging modalities
Sensitivity Specificity
SPECT 87% 73%
PET 89% 86%
CMR 89% 80%
Echocardiography 82% 84%
CT angiography 81% 93%
Reported sensitivities and specificities derived from pooled data for
the major imaging modalities. Note that these values are influenced by
the prevalence of true disease in the study population, which are not
balanced across modalities. Thus, the relatively low specificity of
SPECT imaging is in part due to the higher prevalence of “false
positives” found in the lower-risk cohort for this modality
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perfusion study was associated with no subsequent events
over a mean follow-up of 277 days in this population [13].
A significant issue with CMR stress perfusion imaging is
thedifficultyinobtainingadequatefirst-passperfusionimages
in the transit time available. A novel solution to this problem
has recently been presented in animal model work by
Spuentrup et al. [14]. They have identified a gadolinium-
containing contrast agent with a high affinity for myocardial
collagen. This agent allows CMR imaging to occur up to an
hour after contrast injection while still retaining differential
distribution of the contrast agent between normal and
ischemic myocardium.
While CMR appears to be capable of replicating the
subjective perfusion findings of the nuclear techniques,
without the risks associated with radioactive tracers, CMR
is capable of much more objective results in the determi-
nation of myocardial ischemia.
The capacity of CMR to quantitate myocardial blood
flow has been elegantly demonstrated by Kurita et al. [15￿],
who compared myocardial blood flow at stress and rest in
normal and stenotic coronary arteries using both Doppler
flow wires and with quantitative first-pass perfusion
imaging of the regional myocardium. Their results showed
a strong correlation between the two techniques and
determined that quantitative first-pass stress perfusion
CMR was capable of identifying physiologically relevant
reduction in blood flow with a sensitivity of 88% and a
specificity of 90% when compared to the flow wire as gold
standard.
More recently, a comparison of fractional flow reserve
(FFR), as determined by flow wire, to stress myocardial
perfusion imaging has been performed in 103 patients with
suspected angina [16]. In this study, FFR was recorded in
all patents’ major epicardial coronary arteries, and stress
perfusion CMR was also performed. Myocardial perfusion
scans identified perfusion defects in 121 of 300 coronary
artery segments, of which 110 were likely subtended by
vessels that had an FFR<0.75 (indicating likely ischemia
downstream). A total of 168 of 179 normally perfused
segments had an FFR>0.75. The sensitivity and specificity
of stress perfusion CMR for the detection of functionally
significant coronary heart disease were 91% and 94%,
respectively, with positive and negative predictive values of
91% and 94% in this study.
The utility of quantifying perfusion CMR for research
purposes is clear; however, given the time and effort
required to produce these results, it has become standard
practice in clinical settings to assess myocardial perfusion
images subjectively. However, quantitative perfusion imaging
by CMR does offer some clinical advantages over subjective
evaluation. Perfusion reserve quantitation is capable of
differentiating moderate from severe stenoses in patients.
Quantitative techniques have also been shown to differ-
entiate triple-vessel from single-vessel CAD, whereas this
is difficult by subjective assessment [17￿￿]. This has
important implications for assessment of prognosis, and
adoption of quantitative methods in CMR perfusion
imaging will need to be considered as stress perfusion
CMR becomes a more widespread modality in routine
clinical assessment.
In addition to the ability of CMR to provide quantitative
information about myocardial perfusion, it offers well-
established and robust imaging of previous myocardial
infarction [18, 19]. The combination of stress perfusion
imaging and infarct visualization has been used to
characterize the differences in appearance of ST elevation
and non-ST elevation MI that may underlie the divergent
natural histories of these injuries [20]. Whether the
combination of infarct imaging by late enhancement
combined with stress perfusion imaging provides comple-
mentary prognostic information in assessing cardiovascular
risk has long been of interest [21￿]. Data have recently
become available addressing this question: 254 patients
who were referred for assessment of symptomatic ischemia
were imaged using both techniques and subsequently
followed for a median of 17 months, with the primary end
point being a composite of death and MI. Both the presence
of infarct and reversible perfusion defects were associated
with a threefold increase in cardiac death or acute MI
(death/MI) when adjusted for each other and for the effects
of patient age and gender (adjusted hazard ratio, 3.31; P<
0.02; and hazard ratio, 3.43; P<0.01, respectively). In
patients without a history of MI who had negative perfusion
scan, infarct presence was associated with an 11-fold hazard
increase in death/MI. Patients with neither perfusion defects
nor infarct had a 98.1% negative annual event rate for death/
MI. For association with major adverse cardiac events, stress
perfusion imaging was the strongest multivariable variable
(hazard ratio, 10.92; P<0.0001). Although further follow-up
with greater patient numbers is required, it appears that the
easily accomplished combination of these two techniques in
one scanning session is likely to provide a powerful
prognostic tool.
CMR Perfusion without Contrast: BOLD Imaging
and Spin Labeling
The safe, noninvasive properties of CMR represent an
important advantage of the technique. This benefit is
somewhat compromised by the intravenous use of
gadolinium-containing contrast agents, especially in
patients with renal failure [22, 23]. Two strategies are
under investigation that may eliminate the need for contrast
agents in perfusion CMR protocols of the future.
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flow techniques from the great vessels to the coronary
artery bed. Ideally, this method could provide direct
quantitation of coronary blood flow in individual epicardial
vessels. This technique is made more challenging by
cardiac and respiratory motion during image acquisition.
Nonetheless, some progress has been made using navigator
sequences to control for vessel motion [24￿].
The second technique takes advantage of the variable
paramagnetic properties of hemoglobin in the oxygenated
and deoxygenated states to directly quantitate the oxygen
status of the myocardium. This technique is very
attractive, as it offers a direct measure of the oxygenation
state of the tissue, hence a direct look at ischemia.
Interestingly, the ability to determine oxygenation state
independently of blood flow may allow us to differenti-
ate true ischemia from the surrogate marker of relative
blood flow [25￿]. Blood oxygen level–dependent (BOLD)
i m ag i n gha sb ee ns ho w nt ob efe a si b l ei nC M R ,b utch a ll e n ge s
remain [26, 27]. Current 1.5-T magnets display a limited
signal-to-noise ratio, which has hampered the application of
BOLD imaging in the determination of myocardial ischemia
in patients. Nevertheless, BOLD imaging has been success-
fully combined with myocardial perfusion studies in a large
animal model in order to calculate myocardial oxygen supply
and demand parameters [28￿]. The MRI data obtained in this
study correlate well with PET values obtained for myocardial
blood flow, myocardial oxygen consumption, and oxygen
extraction fraction.
More recently, application of BOLD imaging on 3-T
magnets has met with some success. Manka et al. [29￿]
performed BOLD imaging on a series of 46 patients who
subsequently underwent coronary angiography to deter-
mine ischemic territories. They report significantly lower
T2* values in ischemic segments of myocardium com-
pared to normal and nonischemic segments. Under
adenosine stress, T2* values increased significantly in
normal segments only.
Jahnke et al. [30￿￿] also recently reported on a series of
50 patients with suspected or known CAD who underwent
CMR at 3.0-T followed by invasive X-ray angiography
within 48 h. BOLD imaging was performed at rest and
under adenosine stress, followed by stress and rest first-pass
perfusion and delayed enhancement imaging. Quantitative
coronary X-ray angiography was used for coronary stenosis
definition. The image quality of BOLD CMR at rest and
during adenosine stress was considered good to excellent in
90% and 84% of the patients, respectively, and BOLD
signal differed significantly between normal myocardium,
myocardium supplied by a stenotic coronary artery, and
infarcted myocardium (P<0.001). These results are encour-
aging, and are likely to be expanded upon as 3-T systems
become more readily available.
Assessment of Ischemia-Induced Contractile
Dysfunction
Dobutamine is both an inotropic and chronotropic agent
whose use in pharmacologic stress protocols with echocar-
diographic and CMR-based imaging of the left ventricular
cavity is well established. Exercise as a stress is also used in
echocardiography, but its use is more problematic in CMR.
The format of the pharmacologic stress studies is
identical regardless of the imaging modality: left ventricular
wall motion is analyzed at baseline, and subsequently at
increasing doses of dobutamine, and if required, atropine—
in order to achieve a target cardiac workload. Areas of
myocardial ischemia declare themselves as workload
increases, and oxygen demand exceeds supply resulting in
the development of wall motion abnormalities (WMA).
Pooled analysis of 13 stress echocardiography studies
including 32,739 patients revealed an annual hard event
rate (death or MI) of 1.2% for a normal stress echocardio-
gram as compared with 7.0% for an abnormal study [31].
These event rates are similar to those identified with stress
perfusion techniques. Additional information about baseline
LV function is obtained in these studies, which is of itself
an important prognostic factor governing outcomes. CMR
image acquisitionoffersthe advantage overechocardiography
of unlimited windows and better coverage of the LV cavity,
and thus may be expected to be more sensitive.
Dobutamine stress CMR also offers the possibility of
supplementing the study with a stress perfusion component.
Thiswouldbeexpectedtoimprove the overall accuracyofthe
test, but until recently no objective data on this approach were
available. Korosoglou et al. [32] have now published a large
cohort of 1,493 patients who were followed for 2 years after
testing. Fifty-three hard events occurred during the follow-up
period. Using multivariable regression analysis, an abnormal
result for wall motion or perfusion during stress yielded
independent prognostic value (for wall motion: adjusted
hazard ratio of 5.9 [95% CI: 2.5–13.6]; and for perfusion:
adjusted HR of 5.4 [95% CI: 2.3–12.9]). The presence of
inducible WMA was of incremental value for the risk
stratification of patients with and without inducible perfusion
deficits. Perfusion deficits contributed to poorer outcome
only in the absence of diagnosed inducible WMA.
Vessel Wall Imaging and Molecular Markers
CT Angiography and Calcium Scoring
Over the last decade, CTangiography and coronary calcium
scanning scoring have emerged as rapid and noninvasive
tools for the assessment of coronary arteries. While the
detection of coronary atherosclerosis with these techniques
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need for medical management of CAD, it remains unclear if
these techniques can provide enough prognostic power to
dictate the need for revascularization on their own.
Significantly, diagnostic evidence of atherosclerosis as
determined by coronary calcium scanning probably does
not confer a markedly increased risk of cardiac events in the
absence of ischemia [34]. The converse is not true. In
patients without significant epicardial coronary stenosis
evident at angiography, a positive stress SPECT is still
found to confer an increased risk of cardiac events [35].
Small, single-center studies examining prognosis follow-
ing CT angiography are beginning to enter the literature.
Russo et al. [36] recently reported on a series of 441
patients with suspected CAD who underwent coronary
16-slice multidetector CT angiography and calcium scoring,
then were subsequently followed for a mean of 32 months
for cardiac death, nonfatal MI, and unstable angina
requiring hospitalization. In this cohort (average age
59.7 years, 72% male), an excellent prognosis was noted
in patients with normal coronary arteries (annualized event
rate of 0.88%). The presence of CAD was diagnosed in
67% of patients and was associated with increased risk for
events, which was higher (8.09% person-year) in patients
with significant coronary stenoses but was not negligible
(3.89%) in subjects with nonobstructive disease. CT
angiography provided an additional incremental prognostic
value as compared with a baseline clinical risk model plus
calcium scoring when considering both nonobstructive
versus obstructive CAD. Interestingly, an independent
predictor of events was the presence of mixed/noncalcified
plaques, regardless of lesion severity.
CMR
CMR is not at present capable of the same degree of spatial
resolution as is available with multislice CT angiography.
This reality has somewhat slowed the development of MR-
based imaging of coronaries in favor of the development of
CT-based modalities. Nevertheless, CMR does offer advan-
tages over CT in its superior ability to characterize the
content of tissues in the vascular wall. This ability to
characterize plaque is of increasing interest, given the
realization that mixed plaques identified by CT may have
prognostic significance over and above luminal narrowing.
The most common approach to vascular wall imaging with
CMR uses dual-inversion recovery prepulses to null the
signal from the coronary lumen blood pool. With such a
noninvasive technique, in vivo human coronary vessel wall
imaging has already been successfully performed [37, 38].
Studies to determine the prognostic significance of vascular
wall findings by CMR remain to be done. A disadvantage
of these techniques is the long scan time required.
However, recent advances in phase-sensitive inversion
recovery techniques may speed image acquisition time [39].
In addition to the T1 and T2-weighted imaging of
vascular wall plaque, it has been proposed that the use of
targeted molecular markers in combination with CMR
imaging would provide the ultimate manifestation of tissue
characterization. A limiting factor in the development of
these molecular markers has been the regulatory hurdles
required for the adoption of any new bioactive compound
that might be used as such a marker.
Given this limitation, the more recent approach to
molecular markers has been to identify paramagnetic
markers that are either already approved for diagnostic or
therapeutic use, or are closely related to these compounds.
Iron compounds represent an important candidate. Iron
particles have been shown to be preferentially endocytosed
by macrophages in the vascular wall, and the presence of
these iron particles can subsequently be identified on CMR
[40]. Several studies have addressed the identification of
regions of vascular inflammation within the vascular bed as
a potential marker of increased cardiac risk. The recruit-
ment of macrophages to atherosclerotic plaque has been
hypothesized to be a marker of plaque instability and
increased risk of thromboembolic events [41]. Thus, the
identification of macrophage-enriched regions of the vas-
culature using iron particles may prove a useful diagnostic
approach.
Conclusions
Cardiac imaging techniques continue to develop at an
impressive pace and the evidence will ultimately deter-
mine which of these techniques demonstrate utility in
clinical medicine and which do not. Today, noninvasive
imaging of the coronary vasculature is highly accurate in
determining both the presence of coronary disease and in
providing useful prognostic information. However,
knowledge of the anatomic appearance of the vascular
bed cannot on its own provide a rational approach to
management of the patient with coronary disease.
Additional information regarding parameters such as left
ventricular function, ischemic burden, and myocardial
viability all provide critical information which helps
direct an appropriate treatment plan.
In the future, cardiac imaging will likely provide informa-
tion not just on the current burden of CAD, but also on the
likelihood of progression of disease. Improved imaging of
vascular inflammation and a better understanding of the
outcomes associated with specific findings on images will
contributetoourknowledge.Theefficientandappropriateuse
ofthesetechnologiesisalreadyimprovingourmanagementof
cardiac ischemia, and this is set to continue.
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